Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-011095
Filing Date
2024-08-06
Accepted
2024-08-06 16:18:39
Documents
76
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ptgx-20240630x10q.htm   iXBRL 10-Q 1772904
2 EX-10.1 ptgx-20240630xex10d1.htm EX-10.1 238530
3 EX-31.1 ptgx-20240630xex31d1.htm EX-31.1 10157
4 EX-31.2 ptgx-20240630xex31d2.htm EX-31.2 10147
5 EX-32.1 ptgx-20240630xex32d1.htm EX-32.1 10087
6 GRAPHIC ptgx-20240630x10q006.jpg GRAPHIC 117944
7 GRAPHIC ptgx-20240630xex10d1001.jpg GRAPHIC 42802
8 GRAPHIC ptgx-20240630xex10d1002.jpg GRAPHIC 1223
9 GRAPHIC ptgx-20240630xex10d1003.jpg GRAPHIC 33355
10 GRAPHIC ptgx-20240630xex10d1005.jpg GRAPHIC 56629
11 GRAPHIC ptgx-20240630xex10d1007.jpg GRAPHIC 78723
12 GRAPHIC ptgx-20240630xex10d1009.jpg GRAPHIC 50178
13 GRAPHIC ptgx-20240630xex10d1011.jpg GRAPHIC 208568
14 GRAPHIC ptgx-20240630xex10d1012.jpg GRAPHIC 679
15 GRAPHIC ptgx-20240630xex10d1013.jpg GRAPHIC 4854
16 GRAPHIC ptgx-20240630xex10d1018.jpg GRAPHIC 167021
17 GRAPHIC ptgx-20240630xex10d1019.jpg GRAPHIC 154178
18 GRAPHIC ptgx-20240630xex10d1020.jpg GRAPHIC 111664
  Complete submission text file 0001558370-24-011095.txt   8528874

Data Files

Seq Description Document Type Size
19 EX-101.SCH ptgx-20240630.xsd EX-101.SCH 44563
20 EX-101.CAL ptgx-20240630_cal.xml EX-101.CAL 59494
21 EX-101.DEF ptgx-20240630_def.xml EX-101.DEF 131170
22 EX-101.LAB ptgx-20240630_lab.xml EX-101.LAB 322265
23 EX-101.PRE ptgx-20240630_pre.xml EX-101.PRE 253809
79 EXTRACTED XBRL INSTANCE DOCUMENT ptgx-20240630x10q_htm.xml XML 1182042
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

EIN.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37852 | Film No.: 241179557
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)